ENDRA Life Sciences Inc.

06/11/2025 | Press release | Distributed by Public on 06/11/2025 06:20

Regulation FD Disclosure (Form 8-K)

Item 7.01 Regulation FD Disclosure

On June 11, 2025, ENDRA Life Sciences Inc. (the "Company") posted to its website an investor presentation reflecting its new business strategy announced in its press release issued on March 31, 2025. The investor presentation may be found on the Company's website at https://investors.endrainc.com.

The information in this Item 7.01 of this Current Report on Form 8-K is intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.

2

ENDRA Life Sciences Inc. published this content on June 11, 2025, and is solely responsible for the information contained herein. Distributed via SEC EDGAR on June 11, 2025 at 12:20 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at support@pubt.io